Clinical Trial Update: Study Evaluating Pantoprazole Sodium Enteric-Coated Spheroid Suspension In Infants With Presumed GERD [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating pantoprazole in infants with presumed gastroesophageal reflux disease has completed and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Pantoprazole sodium enteric-coated suspension (pantoprazole)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Gastroesophageal Reflux | Phase 3 | Status: COMPLETED | Results posted: 2010-05-07